Braeburn
Dr. Jerry Karabelas has held a number of senior executive positions in major pharmaceutical companies, including Head of Healthcare and CEO of Worldwide Pharmaceuticals for Novartis AG, where he had full responsibility for Novartis Pharma and Ciba Vision, as well as strategic and operational leadership of R&D. He was also Executive Vice President of SmithKline Beecham with responsibility for U.S. and European operations, regulatory, and strategic marketing. Most recently, Jerry has chaired the boards of several biopharmaceutical companies, including Human Genome Sciences, Inc., Vanda Pharmaceuticals, Inc., and SkyePharma PLC. He currently chairs the boards of Inotek and Polyphor, AG, and is a partner at Care Capital.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Braeburn
Braeburn is dedicated to delivering solutions for people living with the serious consequences of opioid use disorder. They are committed to advancing next-generation therapies, with individualized dosing regimens and delivery options, to address the escalating disease burden of opioid use disorder faced by patients, healthcare professionals, payers and society.